Menu Search
Equities

Sinopharm Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
X2S:STU

Sinopharm Group Co Ltd

Actions
  • Price (EUR)2.29
  • Today's Change0.053 / 2.37%
  • Shares traded0.00
  • 1 Year change-4.19%
  • Beta0.5120
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Sinopharm Group Co Ltd is a China-based company principally engaged in the wholesale and retail of pharmaceutical and healthcare products and medical devices. The Company operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.

  • Revenue in HKD (TTM)652.17bn
  • Net income in HKD7.71bn
  • Incorporated2003
  • Employees100.25k
  • Location
    Sinopharm Group Co LtdSinopharm Group Building, No. 385, EastSHANGHAI 200023ChinaCHN
  • Phone+86 2 123052666
  • Fax+86 2 123052888
  • Websitehttps://www.sinopharmgroup.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.